Valeria Kogan, PhD, Founder and CEO of Fermata has been recognized as one of Forbes' “30 Under 30” in 2022, Valeria is a serial entrepreneur with a proven track record in biotechnology and innovation.

In the first serious fallout from President Donald Trump's early actions against offshore wind power, oil and gas giant Shell ...

A group of researchers from the University of the Philippines-Los Banos (UPLB) developed an all-natural biopesticide that can ...

This article explores the transformative potential and challenges of single cell omics in advancing our understanding of ...

The best regions to practice dormant seeding in February include Northern and transitional areas where cool-season grasses ...

Nearly 2,000 workers in Alabama were laid off in mass layoffs and plant closures in 2024, according to WARN notices filed with the Alabama Department of Commerce. About 21 employers in industries ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

By Milliam MurigiAs climate change intensifies, rising temperatures and increasingly unpredictable weather patterns create ...

A European research-led consortium has been established to pioneer technologies to improve crop resilience to drought stress ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.